WASHINGTON — The U.S. Defense Department is weighing a new search for immune-protein “cocktails” it hopes will protect humans against Ebola and other deadly, weapon-usable viruses.
The Pentagon two weeks ago invited scientists to submit research proposals for designing “monoclonal antibodies” that could protect against Ebola and Marburg, as well as “alphaviruses” such as Venezuelan equine encephalitis.
Pentagon planners have been turning to antibodies as a possible tool because “no easy and quick fix” for such agents has emerged from efforts to develop vaccines or traditional antiviral treatments, said Gigi Gronvall, a senior associate with the Center for Health Security at the University of Pittsburgh Medical Center.
The early-stage research now under consideration ideally would lead to single-shot treatments capable of guarding troops for months from multiple virus types, the Defense Threat Reduction Agency said in a Sept. 18 solicitation. DTRA officials welcomed researchers to propose “‘cocktails’ that may enable cross-protection against multiple species of virus.”
The emphasis on “cocktails” makes the latest DTRA proposal particularly notable, because several studies suggest that mixes of several antibodies can be particularly effective in fighting pathogens, Gronvall told Global Security Newswire in a telephone interview. Antibodies hit their targets with such specificity that a treatment with multiple immune proteins can help account for slight variations between invading microbes.
Monoclonal antibodies have been in use since the 1980s to treat cancer and immune-linked ailments such as rheumatoid arthritis, but their use against infectious pathogens has lagged, according to a DTRA-sponsored report co-authored by Gronvall on the technology’s biodefense potential.
The United States last year licensed the first inhalation anthrax treatment to use the technology, which involves creating massive quantities of a single immune “antibody.” The human body naturally generates such proteins, each of which is designed to mark a specific pathogen or toxin for elimination by other immune-system components.
One antibody cocktail grown in modified tobacco plants showed promising potency against Ebola infections specifically, according to a study published in August.
“There have been a lot of changes in the way that monoclonal antibody technologies have evolved over the last several years, and it makes monoclonal antibodies a very nice piece of their approach to medical countermeasures,” Gronvall said.
The latest DTRA Broad Agency Announcement seeks proposals for studies no longer than one year, with a cost no greater than $500 million. The filing deadline is Oct. 16.
What We're Following See More »
First, it was Sean Spicer. Then Reince Priebus. Now, presidential adviser Steve Bannon, perhaps the administration's biggest lightning rod for criticism, is out. “White House Chief of Staff John Kelly and Steve Bannon have mutually agreed today would be Steve’s last day,” the White House press secretary, Sarah Huckabee Sanders, said in a statement. “We are grateful for his service and wish him the best.” That's not to say the parting of ways isn't controversial. Bannon says he submitted his resignation on Aug. 7, but earlier today, "the president had told senior aides that he had decided to remove Mr. Bannon."
"The Trump administration has ended Operation Choke Point, the anti-fraud initiative started under the Obama administration that many Republicans argued was used to target gun retailers and other businesses that Democrats found objectionable. Assistant Attorney General Stephen Boyd told GOP representatives in a Wednesday letter that the long-running program had ended, bringing a conclusion to a chapter in the Obama years that long provoked and angered conservatives who saw Choke Point as an extra-legal crackdown on politically disfavored groups."
"Liberal groups are raising questions about a speaking appearance Supreme Court Justice Neil Gorsuch plans to make next month at the Trump International Hotel in Washington. Gorsuch is scheduled to headline a luncheon celebrating the 50th anniversary of conservative group The Fund for American Studies on September 28, days before the next SCOTUS term begins October 2. Steve Slattery, a spokesman for The Fund for American Studies, said Gorsuch had nothing to do with venue choice, which was made long before the group asked Gorsuch to speak."
"The Trump administration has lost a handful of individuals serving in top cybersecurity roles across the federal government in recent weeks, even as it has struggled to fill high-ranking IT positions. The developments present hurdles for the new administration and speak to the longstanding challenge the federal government faces in competing with the private sector for top tech talent." Among those resigning is Richard Staropoli, "a former U.S. Secret Service agent who served as chief information officer (CIO) of the Department of Homeland Security for just three months," and Dave DeVries, the CIO at OPM. Separately, the White House announced today that President Trump has directed that United States Cyber Command be elevated to the status of a Unified Combatant Command focused on cyberspace operations.